Post-transfusion purpura caused by anti-HPA-3a antibodies that are only detectable using whole platelets in the platelet immunofluorescence test.
Barba
P
P
Pallarés
P
P
Nogués
N
N
Canals
C
C
Gracia
M
M
Vinyets
I
I
Muñiz-Diaz
E
E
D016824:Antigens, Human Platelet / Q000276:immunology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001792:Blood Platelets / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D017707:Erythrocyte Transfusion; D005188:False Negative Reactions; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D006801:Humans; D016867:Immunocompromised Host; D007518:Isoantibodies / Q000032:analysis / Q000276:immunology*; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications; D017713:Platelet Transfusion / Q000009:adverse effects*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000209:etiology*; D012772:Shock, Septic / Q000209:etiology / Q000628:therapy; D013203:Staphylococcal Infections / Q000209:etiology
C044561:3a alloantigen, human; D016824:Antigens, Human Platelet; D007518:Isoantibodies